Glovista Investments’s Gilead Sciences GILD Stock Holding History

Glovista Investments’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-7,535	Closed	-$610K	–	109
2017 Q3	$610K	Sell	7,535 -750	-9%	-$57.4K	0.12%	71
2017 Q2	$586K	Sell	8,285 -50	-0.6%	-$3.33K	0.13%	75
2017 Q1	$566K	Hold	8,335	–	–	0.13%	80
2016 Q4	$597K	Hold	8,335	–	–	0.11%	55
2016 Q3	$659K	Buy	8,335 +250	+3%	+$20.3K	0.13%	49
2016 Q2	$674K	Sell	8,085 -400	-5%	-$35.5K	0.12%	57
2016 Q1	$779K	Buy	8,485 +2,675	+46%	+$241K	0.13%	48
2015 Q4	$588K	Buy	5,810 +1,000	+21%	+$104K	0.1%	46
2015 Q3	$472K	Hold	4,810	–	–	0.07%	43
2015 Q2	$563K	Buy	4,810 +200	+4%	+$21.9K	0.06%	45
2015 Q1	$452K	Hold	4,610	–	–	0.05%	61
2014 Q4	$435K	Hold	4,610	–	–	0.06%	61
2014 Q3	$491K	Hold	4,610	–	–	0.06%	59
2014 Q2	$382K	Buy	4,610 +125	+3%	+$9.73K	0.05%	70
2014 Q1	$318K	Buy	+4,485	New	+$352K	0.05%	74

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Glovista Investments's GILD Position: Q4 2017 in Review

Glovista Investments sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 7,535 shares — an estimated $610K sold.

Glovista Investments first reported a position in GILD in Q1 2014 and held it in 15 quarters. The position peaked at $779K in Q1 2016. 1,575 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

Glovista Investments reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
Glovista Investments sold 7,535 Gilead Sciences shares in Q4 2017, an estimated $610K.
Glovista Investments first reported a position in Gilead Sciences in Q1 2014 and held it in 15 quarters.
Glovista Investments's Gilead Sciences position peaked at $779K in Q1 2016.
1,575 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Glovista Investments's 13F filing for Q4 2017, filed 15 Feb 2018.